Company Filing History:
Years Active: 1988
Title: **Innovations of Takashi Iguro: Pioneering Cancer Diagnostics**
Introduction
Takashi Iguro, an accomplished inventor based in Torrance, California, has made significant contributions to the field of cancer diagnostics. With a keen focus on the molecular basis of tumors, his innovative work has led to advancements in the detection and treatment of neoplastic conditions.
Latest Patents
Iguro holds a pivotal patent titled "Sialylated Lewis.sup.x epitope, antibodies and diagnosis," which revolves around the detection of sialylated Lewis.sup.x antigen in sera. This diagnostic approach is instrumental in identifying the presence of cancer, as it provides an efficient means of diagnosing a variety of different tumors. His patent includes the provision of monoclonal antibodies that are proven to be useful in clinical settings, enhancing the accuracy of cancer diagnoses. Notably, the hybridoma CSLEX1 related to this innovation was deposited at the A.T.C.C. on June 20, 1984, and assigned the Accession No. HB8580.
Career Highlights
Throughout his career, Takashi Iguro has worked at the University of California, contributing to cutting-edge research and development in the medical field. His focus on antibodies and their applications in cancer diagnostics has solidified his reputation as a leading innovator. The impactful outcomes of his research continue to benefit clinicians and patients alike.
Collaborations
Iguro has collaborated with esteemed colleagues such as Paul I Terasaki and Masaki Hirota. These partnerships have fostered a creative research environment that has propelled advancements in the understanding of cancer and its detection methods. Together, they have reinforced the importance of teamwork in achieving groundbreaking results in health science.
Conclusion
In summary, Takashi Iguro's innovative work in cancer diagnostics has had a profound impact on the medical community. His patent not only reflects his dedication as an inventor but also highlights the ongoing need for advanced diagnostic tools in the fight against cancer. As research continues to evolve, Iguro's contributions serve as a vital part of the journey toward improved healthcare solutions.